Back to News
Market Impact: 0.25
SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of September 28, 2026 in Capricor Therapeutics, Inc. Lawsuit
Source: globenewswire.com
Legal & LitigationCompany FundamentalsInvestor Sentiment & Positioning
Capricor Therapeutics (CAPR) faces a shareholder class action alleging claims for investors who bought shares between Dec. 17, 2025 and July 26, 2026. While no financial figures are provided, this type of legal filing is a potential near-term overhang for sentiment and trading as eligibility for recovery is assessed.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.35
Ticker Sentiment
CAPR-0.80
More News
- Why is T-Mobile stock tumbling today?
- Why is Verizon stock sliding today?
- SpaceX wants to become a 'major mobile carrier' with low-band spectrum acquisition
- OpenAI projected to bring in $20bn less in revenue than expected
- Soitec climbs 7% as BofA turns bullish on silicon photonics demand
- Schott Pharma drops after Deutsche Bank downgrades on demanding valuation
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- AllMind's Data Standardization Methodology: Our Approach to Fundamentals
- What Makes Financial Data Ready for AI Research?